绝经前女性桡骨远端骨折后骨代谢标志物与骨材料强度的纵向变化
本研究纳入34例绝经前女性桡骨远端骨折患者和39例无骨折对照,纵向检测血清骨代谢标志物(MBM)并评估骨密度与骨材料强度指数。多数MBM在伤后6周达峰值,硬骨素在1年时仍低于基线而DKK1高于基线;骨折严重度与P1NP和BSAP升高相关;骨密度和骨材料强度指数未能区分骨折与对照。
要点
- 桡骨远端骨折后多数骨代谢标志物在6周达峰,6个月内逐渐下降。
- 伤后1年硬骨素仍低于基线、DKK1仍高于基线。
- 骨折越严重,P1NP和BSAP升高幅度越大。
核心结论
- 桡骨远端骨折引起多种骨代谢标志物升高,多在伤后6周达峰并在6个月内逐渐下降。
- 伤后1年硬骨素仍低于基线而DKK1仍高于基线。
- 骨折严重度越高,P1NP和BSAP变化越大。
- 骨密度和骨材料强度指数未能区分骨折患者与对照。
研究设计与样本
- 纳入绝经前女性桡骨远端骨折患者34例和无骨折对照39例。
- 在初诊时、6周、3个月、6个月和12个月检测血清骨代谢标志物。
- 骨密度用双能X线吸收法评估,骨材料强度指数用微压痕法评估。
主要发现
- 多数骨代谢标志物在伤后6周达峰值,包括骨钙素升高17.7%、硬骨素升高23.5%、DKK1升高12.6%。
- 伤后1年硬骨素较基线降低27.4%,DKK1较基线升高22.2%。
- CTX在6个月和12个月降至基线以下,TRAP5b、BSAP和骨膜蛋白无显著变化。
- 12个月时骨折组硬骨素低于对照组(p=0.003)、DKK1高于对照组(p=0.03)。
- 骨折严重度越高,P1NP和BSAP升高幅度越大。
关键数值与推荐
- 骨代谢标志物包括25(OH)维生素D、PTH、骨钙素、P1NP、BSAP、CTX、硬骨素、DKK1、骨膜蛋白和TRAP5b。
临床怎么用
- 对绝经前女性桡骨远端骨折患者,可关注伤后6周骨代谢标志物峰值及1年时硬骨素和DKK1的持续变化。
- 骨折严重度较高者P1NP和BSAP变化更明显,可据此评估骨代谢反应。
- 骨密度和骨材料强度指数不宜用于区分绝经前女性桡骨远端骨折与无骨折者。
局限性
- 研究样本量较小(骨折组34例、对照组39例)。
- 证据等级为预后II级。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Markers of bone metabolism (MBM) play an important role in fracture evaluation, and changes have been associated with increased fracture risk. The purpose of the present study was to describe changes in MBM in premenopausal women with distal radial fractures. METHODS: Premenopausal women with distal radial fractures (n = 34) and without fractures (controls) (n = 39) were recruited. Serum MBM in patients with distal radial fractures were obtained at the time of the initial presentation, 6 weeks, and 3, 6, and 12 months. MBM included 25(OH) vitamin D, PTH, osteocalcin, P1NP, BSAP, CTX, sclerostin, DKK1, periostin, and TRAP5b. Areal bone mineral density (aBMD) was assessed with dual x-ray absorptiometry, and the bone material strength index (BMSi) was assessed with microindentation. RESULTS: Most MBM reached peak levels at 6 weeks after the injury, including osteocalcin (+17.7%), sclerostin (+23.5%), and DKK1 (12.6%). Sclerostin was lower (-27.4%) and DKK1 was higher (+22.2%) at 1 year after the fracture. CTX declined below baseline levels at 6 and 12 months, whereas TRAP5b, BSAP, and periostin did not significantly change. At 12 months, sclerostin was lower (p = 0.003) and DKK1 was higher (p = 0.03) in the distal radial fracture group than in the control group. Greater fracture severity was associated with greater increases in P1NP and BSAP. aBMD and BMSi were not associated with fracture. CONCLUSIONS: Distal radial fractures caused increases in several MBM, which typically peaked at 6 weeks after injury and gradually decreased over 6 months. Sclerostin and DKK1 remained below and above baseline at 1 year, respectively. Increasing fracture severity resulted in larger changes in MBM. aBMD and BMSi did not discriminate between patients with distal radial fractures and controls. Continued efforts to identify markers of skeletal fragility in young women are warranted to mitigate future fracture risk. LEVEL OF EVIDENCE: Prognostic Level II. See Instructions for Authors for a complete description of levels of evidence.
引用
- Rozental TD, Merchan N, Johannesdottir F, et al. Longitudinal Changes in Serum Markers of Bone Metabolism and Bone Material Strength in Premenopausal Women with Distal Radial Fracture. J Bone Joint Surg Am. 2022. PMID: 34648480. doi:10.2106/JBJS.21.00540
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。